Skip to content

Study to Improve the Treatment of Patients With Heart Failure by General Practitioners

Therapy OPtimization Heart Failure Utrecht

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01662323
Acronym
TOPHU
Enrollment
683
Registered
2012-08-10
Start date
2009-06-30
Completion date
2012-06-30
Last updated
2012-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Heart failure, general practitioner, medical therapy, quality of live

Brief summary

The purpose of this study is to determine whether it is possible to improve the care of general practitioners for patients with heart failure. The investigators try to reach that goal by training the GP's for 90 minutes in uptitrating the recommended medication according the guidelines. After 6 month the investigators ask the patients to fill out a questionary. The investigators ask them about their quality of live.

Interventions

BEHAVIORALGP's treating HF according the dutch guidelines

Sponsors

Agis Zorgverzekeringen
CollaboratorOTHER
Julius Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Do have a general practitioners diagnosis heart failure mentioned twice in the electronical medical file.

Exclusion criteria

* Incapacitated patients with a life expectancy of less than 2 months * Seniles * Patients who do not speak the Dutch language

Design outcomes

Primary

MeasureTime frameDescription
proportion recommended medication for patients with heart failureup to 6 monthsthe proportion patient who got at the end of the study the tree medicaments which should be prescribed to a patient with heart failure.

Secondary

MeasureTime frameDescription
QoLup to 1 yearMeasurement of quality of live six months after uptitration of the recommended medication.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026